专利检索 ap:("Cytokinetics, Inc.") AND inv:"Alex R Muci" 第 1 页

1.

发明申请
CERTAIN AMINO-PYRIDINES AND AMINO-TRIAZINES, COMPOSITIONS THEREOF, AND METHODS FOR THEIR USE 审中-公开

公开(公告)号：US20160200717A1

公开(公告)日：2016-07-14

申请号：US14823605

申请日：2015-08-11

申请人： Cytokinetics, Inc.

发明人： Luke W. Ashcroft , Gustave Bergnes , Scott Collibee , Chihyuan Chuang , Jeff Gardina , Bradley P. Morgan , Alex R Muci , Xiangping Qian , Antonio Romero , Jeffrey Warrington , Zhe Yang

IPC分类号： C07D417/14 , C07D213/75 , C07D401/14 , C07D253/07 , C07D403/04 , C07D213/74 , C07D401/12

CPC分类号： C07D213/74 , C07D213/75 , C07D213/78 , C07D213/82 , C07D215/38 , C07D215/48 , C07D253/07 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/10 , C07D417/04 , C07D417/14

摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R2, R4, R5, R6, R7, R8, R9, X, Z1, Z2, Z3, Z4 and m are as defined herein.Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.

2.

发明授权
Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use 有权

公开(公告)号：US09994528B2

公开(公告)日：2018-06-12

申请号：US14823605

申请日：2015-08-11

申请人： Cytokinetics, Inc.

发明人： Luke W. Ashcraft , Gustave Bergnes , Scott Collibee , Chihyuan Chuang , Jeff Gardina , Bradley P. Morgan , Alex R Muci , Xiangping Qian , Antonio Romero , Jeffrey Warrington , Zhe Yang

IPC分类号： C07D213/74 , C07D213/75 , C07D401/12 , C07D401/14 , C07D417/14 , C07D417/04 , C07D403/04 , A61K31/44 , A61K31/4427 , A61P21/00 , A61P21/04 , C07D213/78 , C07D213/82 , C07D215/48 , C07D253/07 , C07D215/38 , C07D403/10

CPC分类号： C07D213/74 , C07D213/75 , C07D213/78 , C07D213/82 , C07D215/38 , C07D215/48 , C07D253/07 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/10 , C07D417/04 , C07D417/14

摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R2, R4, R5, R6, R7, R8, R9, X, Z1, Z2, Z3, Z4 and m are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.